Page 42 - JCBP-2-1
P. 42

Journal of Clinical and
            Basic Psychosomatics                                                        The endocannabinoid system



               between the immune and the endocannabinoid systems in   Endocannabinoids have opposing effects on behavioral
               cancer. Cells, 10: 1282.                           responses to nociceptive and non-nociceptive stimuli.  Sci
                                                                  Rep, 7: 5793.
               https://doi.org/10.3390/cells10061282
                                                                  https://doi.org/10.1038/s41598-017-06114-1
            128. Durieux LJ, Gilissen SR, Arckens L, 2021, Endocannabinoids
               and cortical plasticity: CB1R as a possible regulator of the   139. Moreno-García Á, Bernal-Chico A, Colomer T,  et al.,
               excitation/inhibition balance in health and disease.  Eur J   2020, Gene expression analysis of astrocyte and microglia
               Neurosci, 55: 971–988.                             endocannabinoid  signaling  during  autoimmune
                                                                  demyelination. Biomolecules, 10: 1228.
               https://doi.org/10.1111/ejn.15110
                                                                  https://doi.org/10.3390/biom10091228
            129. Cohen L,  Neuman MG, 2020,  Cannabis and the
               gastrointestinal tract. J Pharm Pharm Sci, 23: 301–313.   140. Maccarrone M, Bab I, Bíró T, et al., 2015, Endocannabinoid
                                                                  signaling at the periphery: 50  years after THC.  Trends
               https://doi.org/10.18433/jpps31242
                                                                  Pharmacol Sci, 36: 277–296.
            130. Dasram MH, Walker RB, Khamanga SM, 2022, Recent
               advances in endocannabinoid system targeting for improved      https://doi.org/10.1016/j.tips.2015.02.008
               specificity: Strategic approaches to targeted drug delivery.   141. Rezende B, Alencar AKN, de Bem GF,  et al., 2023,
               Int J Mol Sci, 23: 13223.                          Endocannabinoid system: chemical characteristics and
                                                                  biological activity. Pharmaceuticals (Basel), 16: 148.
               https://doi.org/10.3390/ijms232113223
                                                                  https://doi.org/10.3390/ph16020148
            131. Finn  DP,  Haroutounian S,  Hohmann  AG,  et al.,  2021,
               Cannabinoids, the endocannabinoid system, and pain:   142. Henson JD, Vitetta L, Quezada M, et al., 2021, Enhancing
               A review of preclinical studies. Pain, 162: S5–S25.   endocannabinoid control of stress with cannabidiol. J Clin
                                                                  Med, 10: 5852.
               https://doi.org/10.1097/j.pain.0000000000002268
                                                                  https://doi.org/10.3390/jcm10245852
            132. Ahmed I, Rehman SU, Shahmohamadnejad S, et al., 2021,
               Therapeutic attributes of endocannabinoid system against   143. Migliaro M, Ruiz-Contreras AE, Herrera-Solís A,  et al.,
               neuro-inflammatory autoimmune disorders.  Molecules,   2023, Endocannabinoid system and aggression across
               26: 3389.                                          animal species. Neurosci Biobehav Rev, 153: 105375.
               https://doi.org/10.3390/molecules26113389          https://doi.org/10.1016/j.neubiorev.2023.105375
            133. Deroon-Cassini TA, Stollenwerk TM, Beatka M,  et al.,   144.  Gunduz-Cinar  O,  2021,  The  endocannabinoid
               2020, Meet your stress management professionals: The   system in the amygdala and modulation of fear.  Prog
               endocannabinoids. Trends Mol Med, 26: 953–968.     Neuropsychopharmacol Biol Psychiatry, 105: 110116.
               https://doi.org/10.1016/j.molmed.2020.07.002       https://doi.org/10.1016/j.pnpbp.2020.110116
            134. Kienzl M, Kargl J, Schicho R, 2020, The immune   145. Garani R, Watts JJ, Mizrahi R, 2021, Endocannabinoid
               endocannabinoid system of the tumor microenvironment.   system in psychotic and mood disorders, a review of
               Int J Mol Sci, 21: 8929.                           human studies. Prog Neuropsychopharmacol Biol Psychiatry,
                                                                  106: 110096.
               https://doi.org/10.3390/ijms21238929
                                                                  https://doi.org/10.1016/j.pnpbp.2020.110096
            135.  Charytoniuk  T,  Zywno  H,  Konstantynowicz-
               Nowicka K, et al., 2020, Can physical activity support the   146. Bielawski T, Albrechet-Souza L, Frydecka D, 2021,
               endocannabinoid system in the preventive and therapeutic   Endocannabinoid system in trauma and psychosis: Distant
               approach to neurological disorders? Int J Mol Sci, 21: 4221.   guardian of mental stability. Rev Neurosci, 32: 707–722.
               https://doi.org/10.3390/ijms21124221               https://doi.org/10.1515/revneuro-2020-0102
            136. Navarro D, Gasparyan A, Navarrete F, et al., 2022, Molecular   147. Meah F, Lundholm M, Emanuele N, et al., 2021, The effects
               alterations of the endocannabinoid system in psychiatric   of cannabis and cannabinoids on the endocrine system. Rev
               disorders. Int J Mol Sci, 23: 4764.                Endocr Metab Disord, 23: 401–420.
               https://doi.org/10.3390/ijms23094764               https://doi.org/10.1007/s11154-021-09682-w
            137. Rakotoarivelo V, Sihag J, Flamand N, 2021, Role of the   148. McEwen BS, Akil H, 2020, Revisiting the stress concept:
               endocannabinoid system in the adipose tissue with focus on   Implications for affective disorders. J Neurosci, 40: 12–21.
               energy metabolism. Cells, 10: 1279.
                                                                  https://doi.org/10.1523/jneurosci.0733-19.2019
               https://doi.org/10.3390/cells10061279
                                                               149. Zieglgänsberger W, Brenneisen R, Berthele, A,  et al.,
            138. Summers T, Hanten B, Peterson W,  et  al., 2017,   2022, Chronic pain and the endocannabinoid system:


            Volume 2 Issue 1 (2024)                         18                       https://doi.org/10.36922/jcbp.2288
   37   38   39   40   41   42   43   44   45   46   47